Sample results from SciSpacy Doc:
==================================================
Tokens and Lemmas:
Token: psychiatry, Lemma: psychiatry
Token: original, Lemma: original
Token: research, Lemma: research
Token: article, Lemma: article
Token: published, Lemma: publish
Token: june, Lemma: june
Token: fpsyt, Lemma: fpsyt
Token: ptsd, Lemma: ptsd
Token: methylation, Lemma: methylation
Token: select, Lemma: select

==================================================
Named Entities Found:
Entity: psychiatry, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: immune function, Type: ENTITY
Entity: promoter regions, Type: ENTITY
Entity: measures, Type: ENTITY
Entity: military service, Type: ENTITY
Entity: rusiecki celia, Type: ENTITY
Entity: zygmunt, Type: ENTITY
Entity: galdzicki vasantha ligong, Type: ENTITY
Entity: andrea baccarelli, Type: ENTITY
Entity: preventive medicine, Type: ENTITY
Entity: school medicine, Type: ENTITY
Entity: services, Type: ENTITY
Entity: university bethesda department, Type: ENTITY
Entity: anatomy, Type: ENTITY
Entity: physiology, Type: ENTITY
Entity: genetics school, Type: ENTITY
Entity: services, Type: ENTITY
Entity: university bethesda epigendx, Type: ENTITY
Entity: exposure, Type: ENTITY
Entity: epidemiology, Type: ENTITY
Entity: harvard school, Type: ENTITY
Entity: roth, Type: ENTITY
Entity: university delaware, Type: ENTITY
Entity: reviewed, Type: ENTITY
Entity: elisabeth binder planck institute, Type: ENTITY
Entity: psychiatry germany, Type: ENTITY
Entity: ehlert, Type: ENTITY
Entity: zurich switzerland, Type: ENTITY
Entity: rusiecki department, Type: ENTITY
Entity: preventive medicine, Type: ENTITY
Entity: school medicine, Type: ENTITY
Entity: services, Type: ENTITY
Entity: jones bridge road, Type: ENTITY
Entity: molecular mechanisms, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: tinct, Type: ENTITY
Entity: expression signatures, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: immune activation, Type: ENTITY
Entity: transcripts, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: pathophysiology, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: process, Type: ENTITY
Entity: intrinsically, Type: ENTITY
Entity: expression, Type: ENTITY
Entity: temporal, Type: ENTITY
Entity: changes, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: promoter regions, Type: ENTITY
Entity: immune system, Type: ENTITY
Entity: genes, Type: ENTITY
Entity: military service, Type: ENTITY
Entity: ptsd diagnosis, Type: ENTITY
Entity: post diagnosis, Type: ENTITY
Entity: methods, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: post, Type: ENTITY
Entity: diagnosis, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: medical record, Type: ENTITY
Entity: service members, Type: ENTITY
Entity: ptsd diagnosis, Type: ENTITY
Entity: post deployment, Type: ENTITY
Entity: sera, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: quan tiﬁed, Type: ENTITY
Entity: speciﬁc sites, Type: ENTITY
Entity: promoter regions, Type: ENTITY
Entity: insulin, Type: ENTITY
Entity: growth long coding transcript, Type: ENTITY
Entity: multivariate analysis, Type: ENTITY
Entity: linear models, Type: ENTITY
Entity: gender race, Type: ENTITY
Entity: temporal, Type: ENTITY
Entity: comparisons, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: post, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: post, Type: ENTITY
Entity: deployment signiﬁcant, Type: ENTITY
Entity: post, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: reduction, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: reduction, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: increase, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: stratiﬁed analyses, Type: ENTITY
Entity: post, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: older service, Type: ENTITY
Entity: males, Type: ENTITY
Entity: service, Type: ENTITY
Entity: white race, Type: ENTITY
Entity: shorter, Type: ENTITY
Entity: deployments, Type: ENTITY
Entity: months, Type: ENTITY
Entity: deployed, Type: ENTITY
Entity: personnel, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: reduced, Type: ENTITY
Entity: levels, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: increased, Type: ENTITY
Entity: levels, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: levels, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: ﬁndings, Type: ENTITY
Entity: investigated, Type: ENTITY
Entity: studies, Type: ENTITY
Entity: keywords, Type: ENTITY
Entity: post, Type: ENTITY
Entity: traumatic stress disorder, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: inﬂammation, Type: ENTITY
Entity: promoter region, Type: ENTITY
Entity: operation, Type: ENTITY
Entity: iraqi freedom, Type: ENTITY
Entity: operation, Type: ENTITY
Entity: freedom, Type: ENTITY
Entity: epigenetics, Type: ENTITY
Entity: introduction, Type: ENTITY
Entity: estimates, Type: ENTITY
Entity: post, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: prevalence, Type: ENTITY
Entity: military service, Type: ENTITY
Entity: afghanistan iraq, Type: ENTITY
Entity: aver ages, Type: ENTITY
Entity: rates, Type: ENTITY
Entity: military populations, Type: ENTITY
Entity: rates, Type: ENTITY
Entity: civilian ulations, Type: ENTITY
Entity: prevalence, Type: ENTITY
Entity: rates, Type: ENTITY
Entity: kessler, Type: ENTITY
Entity: prevalence, Type: ENTITY
Entity: kessler breslau, Type: ENTITY
Entity: molecular mechanisms, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: sustained, Type: ENTITY
Entity: stress sympathetic nervous system, Type: ENTITY
Entity: hyper, Type: ENTITY
Entity: arousal state, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: immune system, Type: ENTITY
Entity: studies, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: alterations, Type: ENTITY
Entity: immune function, Type: ENTITY
Entity: increased, Type: ENTITY
Entity: canonical inﬂammatory cytokines spivak, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: maes sutherland, Type: ENTITY
Entity: kanel, Type: ENTITY
Entity: decreased, Type: ENTITY
Entity: levels, Type: ENTITY
Entity: anti, Type: ENTITY
Entity: inﬂammatory cytokines kawa, Type: ENTITY
Entity: kanel smith, Type: ENTITY
Entity: proﬁling, Type: ENTITY
Entity: cdna microarrays, Type: ENTITY
Entity: peripheral blood triggering, Type: ENTITY
Entity: development, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: trauma, Type: ENTITY
Entity: survivors, Type: ENTITY
Entity: emergency room, Type: ENTITY
Entity: months, Type: ENTITY
Entity: expression signatures, Type: ENTITY
Entity: promoter regions, Type: ENTITY
Entity: genes, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: patients, Type: ENTITY
Entity: segman zieker, Type: ENTITY
Entity: expression signatures, Type: ENTITY
Entity: transcripts, Type: ENTITY
Entity: immune activation, Type: ENTITY
Entity: insulin, Type: ENTITY
Entity: growth inﬂammatory, Type: ENTITY
Entity: neuroprotective chemokine, Type: ENTITY
Entity: inﬂammatory, Type: ENTITY
Entity: interleukin interleukin zieker, Type: ENTITY
Entity: ﬁndings, Type: ENTITY
Entity: expression genes, Type: ENTITY
Entity: immune cell function, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: ptsd world, Type: ENTITY
Entity: trade center, Type: ENTITY
Entity: sarapas bosnian, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: nowotny, Type: ENTITY
Entity: epigenetic mechanism, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: pathophysiology, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: process, Type: ENTITY
Entity: regulation, Type: ENTITY
Entity: epigenetic mech, Type: ENTITY
Entity: anisms, Type: ENTITY
Entity: regulation chromatin structure, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: regulators transcrip tion, Type: ENTITY
Entity: sweatt, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: changes, Type: ENTITY
Entity: silence, Type: ENTITY
Entity: decrease, Type: ENTITY
Entity: increase, Type: ENTITY
Entity: expression, Type: ENTITY
Entity: epigenetic molecular mecha, Type: ENTITY
Entity: nisms, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: long term, Type: ENTITY
Entity: behavioral, Type: ENTITY
Entity: active regulation, Type: ENTITY
Entity: epigenetic molecular mechanisms, Type: ENTITY
Entity: formation, Type: ENTITY
Entity: stabilization, Type: ENTITY
Entity: triggered, Type: ENTITY
Entity: fear conditioning, Type: ENTITY
Entity: pocampus amygdala, Type: ENTITY
Entity: studies, Type: ENTITY
Entity: laboratory animals, Type: ENTITY
Entity: zovkic, Type: ENTITY
Entity: sweatt humans, Type: ENTITY
Entity: potential, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: immune function genes, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: methylation microarrays, Type: ENTITY
Entity: assay sites, Type: ENTITY
Entity: peripheral blood, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: methylation genes, Type: ENTITY
Entity: immune system functions, Type: ENTITY
Entity: regulates, Type: ENTITY
Entity: innate, Type: ENTITY
Entity: unmethylated, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: african amer, Type: ENTITY
Entity: psychosocial stress, Type: ENTITY
Entity: global, Type: ENTITY
Entity: andgene speciﬁcdnamethylationpatternspotentiallyassociated, Type: ENTITY
Entity: peripheral, Type: ENTITY
Entity: immune dysregulation smith, Type: ENTITY
Entity: growth tors, Type: ENTITY
Entity: transcripts, Type: ENTITY
Entity: cytokines chemokines, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: paternally imprinted, Type: ENTITY
Entity: maternally imprinted long coding transcript, Type: ENTITY
Entity: segman, Type: ENTITY
Entity: nowotny, Type: ENTITY
Entity: sarapas smith, Type: ENTITY
Entity: moter region, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: methyl cytosine serum, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: military soldiers, Type: ENTITY
Entity: deployed, Type: ENTITY
Entity: afghanistan opera, Type: ENTITY
Entity: tion, Type: ENTITY
Entity: freedom, Type: ENTITY
Entity: iraq operation, Type: ENTITY
Entity: iraqi freedom, Type: ENTITY
Entity: unique, Type: ENTITY
Entity: investigate, Type: ENTITY
Entity: temporal, Type: ENTITY
Entity: changes, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: patterns, Type: ENTITY
Entity: ment, Type: ENTITY
Entity: aproxyforexposuretoapotentiallytraumaticevent, Type: ENTITY
Entity: post, Type: ENTITY
Entity: deployment samples, Type: ENTITY
Entity: evaluations, Type: ENTITY
Entity: temporal, Type: ENTITY
Entity: changes, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: investigate, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: patterns, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: human, Type: ENTITY
Entity: brain tissue, Type: ENTITY
Entity: invasive, Type: ENTITY
Entity: invasive, Type: ENTITY
Entity: biomarker, Type: ENTITY
Entity: epigenetic patterns, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: clinical value studies, Type: ENTITY
Entity: expression signatures, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: psychiatric disorders, Type: ENTITY
Entity: periph eral blood, Type: ENTITY
Entity: segman, Type: ENTITY
Entity: nowotny, Type: ENTITY
Entity: sarapas smith, Type: ENTITY
Entity: knowledge serum, Type: ENTITY
Entity: speciﬁc, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: serum cerebrospinal ﬂuid, Type: ENTITY
Entity: correlation, Type: ENTITY
Entity: cytokine, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: biomarker, Type: ENTITY
Entity: tissues, Type: ENTITY
Entity: signiﬁcance serum, Type: ENTITY
Entity: surrogate, Type: ENTITY
Entity: indicator, Type: ENTITY
Entity: differential response, Type: ENTITY
Entity: vulnerability, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: studies, Type: ENTITY
Entity: biologic samples, Type: ENTITY
Entity: onset disease, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: exposure, Type: ENTITY
Entity: serum, Type: ENTITY
Entity: samples, Type: ENTITY
Entity: military service, Type: ENTITY
Entity: department, Type: ENTITY
Entity: defense serum, Type: ENTITY
Entity: stored, Type: ENTITY
Entity: sera, Type: ENTITY
Entity: iden tiﬁed, Type: ENTITY
Entity: samples, Type: ENTITY
Entity: post, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: materials methods, Type: ENTITY
Entity: population population, Type: ENTITY
Entity: rusiecki target population, Type: ENTITY
Entity: male, Type: ENTITY
Entity: female, Type: ENTITY
Entity: army marines, Type: ENTITY
Entity: service, Type: ENTITY
Entity: ﬁrst deployment january, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: months, Type: ENTITY
Entity: query, Type: ENTITY
Entity: medical records, Type: ENTITY
Entity: international classiﬁcation diseases, Type: ENTITY
Entity: revision codes, Type: ENTITY
Entity: absence, Type: ENTITY
Entity: mental diagnoses, Type: ENTITY
Entity: dating, Type: ENTITY
Entity: years, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: confounding, Type: ENTITY
Entity: psychiatric illnesses, Type: ENTITY
Entity: expression, Type: ENTITY
Entity: mill, Type: ENTITY
Entity: shimabukuro, Type: ENTITY
Entity: iwamoto, Type: ENTITY
Entity: kato gavin, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: encounter, Type: ENTITY
Entity: schizophrenia, Type: ENTITY
Entity: code, Type: ENTITY
Entity: polar disorders, Type: ENTITY
Entity: code manic, Type: ENTITY
Entity: code, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: post, Type: ENTITY
Entity: dodsr criteria, Type: ENTITY
Entity: outpatient records, Type: ENTITY
Entity: mary diagnosis, Type: ENTITY
Entity: chronic ptsd, Type: ENTITY
Entity: code ﬁrst diagnostic position ﬁrst outpatient diagnosis, Type: ENTITY
Entity: months, Type: ENTITY
Entity: ﬁrst deployment, Type: ENTITY
Entity: outpatient, Type: ENTITY
Entity: diagnosis, Type: ENTITY
Entity: psychiatry, Type: ENTITY
Entity: volume article, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: years, Type: ENTITY
Entity: criteria, Type: ENTITY
Entity: inclusion case serum, Type: ENTITY
Entity: sample deployment, Type: ENTITY
Entity: sample, Type: ENTITY
Entity: months, Type: ENTITY
Entity: ﬁrst deployment sample, Type: ENTITY
Entity: sample, Type: ENTITY
Entity: months, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: gender, Type: ENTITY
Entity: females, Type: ENTITY
Entity: males, Type: ENTITY
Entity: identiﬁed, Type: ENTITY
Entity: active duty service, Type: ENTITY
Entity: group, Type: ENTITY
Entity: stratiﬁed random sample, Type: ENTITY
Entity: gender race, Type: ENTITY
Entity: diagnosis, Type: ENTITY
Entity: ptsd code, Type: ENTITY
Entity: matic brain injury codes, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: ptsd diagnosis, Type: ENTITY
Entity: exposure, Type: ENTITY
Entity: data, Type: ENTITY
Entity: assessment, Type: ENTITY
Entity: trauma, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: exposure, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: department, Type: ENTITY
Entity: defense policy, Type: ENTITY
Entity: dodsr samples, Type: ENTITY
Entity: tact, Type: ENTITY
Entity: subjects, Type: ENTITY
Entity: serum medical encounter, Type: ENTITY
Entity: data sample, Type: ENTITY
Entity: laboratory methods, Type: ENTITY
Entity: extraction, Type: ENTITY
Entity: ptsd case, Type: ENTITY
Entity: forces, Type: ENTITY
Entity: surveil, Type: ENTITY
Entity: identiﬁed, Type: ENTITY
Entity: serum, Type: ENTITY
Entity: sample samples, Type: ENTITY
Entity: contin, Type: ENTITY
Entity: dodsr, Type: ENTITY
Entity: chargeswitch gdna serum invitrogen carlsbad, Type: ENTITY
Entity: qubit dsdna assay, Type: ENTITY
Entity: qubit, Type: ENTITY
Entity: invitrogen carlsbad, Type: ENTITY
Entity: quantiﬁcation, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: bisulﬁte treatment, Type: ENTITY
Entity: treated, Type: ENTITY
Entity: zymo methylation zymo, Type: ENTITY
Entity: research orange assays, Type: ENTITY
Entity: bias testing, Type: ENTITY
Entity: testing, Type: ENTITY
Entity: input gdna, Type: ENTITY
Entity: bisulﬁte modiﬁcation, Type: ENTITY
Entity: assay mini, Type: ENTITY
Entity: bisulﬁte, Type: ENTITY
Entity: minimum, Type: ENTITY
Entity: bisulﬁte, Type: ENTITY
Entity: conversion, Type: ENTITY
Entity: input, Type: ENTITY
Entity: bisulﬁte modiﬁcation, Type: ENTITY
Entity: puriﬁcation, Type: ENTITY
Entity: loss procedure bisulﬁte, Type: ENTITY
Entity: treated, Type: ENTITY
Entity: volume, Type: ENTITY
Entity: cycles, Type: ENTITY
Entity: primers biotinylated, Type: ENTITY
Entity: sequenced pyrosequencing system qiagen pyrosequencing, Type: ENTITY
Entity: facturer instructions, Type: ENTITY
Entity: qiagen pyrosequencing pyrosequencing real time sequencing, Type: ENTITY
Entity: mutation analysis, Type: ENTITY
Entity: methy lation analysis, Type: ENTITY
Entity: technology methylation, Type: ENTITY
Entity: locuswasanalyzed, Type: ENTITY
Entity: qiagen pyrosequencing loci speciﬁc cpgs, Type: ENTITY
Entity: promoter region, Type: ENTITY
Entity: ciﬁc loci, Type: ENTITY
Entity: shore, Type: ENTITY
Entity: transcriptional, Type: ENTITY
Entity: site loci, Type: ENTITY
Entity: promoter regions, Type: ENTITY
Entity: tional start, Type: ENTITY
Entity: investigated, Type: ENTITY
Entity: promoter binding region enhancer, Type: ENTITY
Entity: blocking, Type: ENTITY
Entity: binding ctcf upstream start site, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: mcdividedbythesumof, Type: ENTITY
Entity: methylated, Type: ENTITY
Entity: unmethylated cytosine, Type: ENTITY
Entity: cytosines, Type: ENTITY
Entity: site, Type: ENTITY
Entity: site, Type: ENTITY
Entity: position mean, Type: ENTITY
Entity: allpositionsmeasuredinapromoterregion startingfrombisulﬁte, Type: ENTITY
Entity: modiﬁcation, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: template, Type: ENTITY
Entity: pyrosequencing, Type: ENTITY
Entity: speciﬁcity ampliﬁcation, Type: ENTITY
Entity: pyrosequencing reactions, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: duplicates, Type: ENTITY
Entity: laboratory personnel, Type: ENTITY
Entity: quality, Type: ENTITY
Entity: coefﬁcients, Type: ENTITY
Entity: variation, Type: ENTITY
Entity: intraclass correlation coefﬁcients iccs, Type: ENTITY
Entity: duplicate, Type: ENTITY
Entity: sepa rate, Type: ENTITY
Entity: variation, Type: ENTITY
Entity: plate effect, Type: ENTITY
Entity: samples, Type: ENTITY
Entity: insufﬁcient, Type: ENTITY
Entity: bisulﬁte, Type: ENTITY
Entity: conversion, Type: ENTITY
Entity: samples, Type: ENTITY
Entity: insufﬁcient, Type: ENTITY
Entity: bisulﬁte, Type: ENTITY
Entity: conversion, Type: ENTITY
Entity: samples, Type: ENTITY
Entity: ﬁnal analyses, Type: ENTITY
Entity: signals, Type: ENTITY
Entity: samples, Type: ENTITY
Entity: signals, Type: ENTITY
Entity: associated yield, Type: ENTITY
Entity: distribution ples, Type: ENTITY
Entity: measured, Type: ENTITY
Entity: measured, Type: ENTITY
Entity: signals, Type: ENTITY
Entity: post, Type: ENTITY
Entity: case status, Type: ENTITY
Entity: deployment case, Type: ENTITY
Entity: signals assay, Type: ENTITY
Entity: instability, Type: ENTITY
Entity: proportions, Type: ENTITY
Entity: statistical methods, Type: ENTITY
Entity: statistical analyses, Type: ENTITY
Entity: promoter, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: measured, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: post, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: post, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: multivariate anova, Type: ENTITY
Entity: post, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: loci speciﬁc, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: gender race, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: trols, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: post, Type: ENTITY
Entity: glms, Type: ENTITY
Entity: case case, Type: ENTITY
Entity: comparisons, Type: ENTITY
Entity: case comparisons, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: post, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: analyses, Type: ENTITY
Entity: stratifying, Type: ENTITY
Entity: gender race, Type: ENTITY
Entity: length deployment, Type: ENTITY
Entity: investigate, Type: ENTITY
Entity: potential, Type: ENTITY
Entity: patterns, Type: ENTITY
Entity: speciﬁc groups, Type: ENTITY
Entity: version, Type: ENTITY
Entity: statistical analyses procedures, Type: ENTITY
Entity: ﬁnal models, Type: ENTITY
Entity: institute, Type: ENTITY
Entity: institutional review, Type: ENTITY
Entity: baseline, Type: ENTITY
Entity: characteristics, Type: ENTITY
Entity: population table, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: subjects, Type: ENTITY
Entity: case yield, Type: ENTITY
Entity: insufﬁcient, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: quantiﬁcation, Type: ENTITY
Entity: measured, Type: ENTITY
Entity: post, Type: ENTITY
Entity: subjects, Type: ENTITY
Entity: neces sarily, Type: ENTITY
Entity: data loci, Type: ENTITY
Entity: measured, Type: ENTITY
Entity: post, Type: ENTITY
Entity: methyla tion, Type: ENTITY
Entity: locus, Type: ENTITY
Entity: population, Type: ENTITY
Entity: case status, Type: ENTITY
Entity: gender race, Type: ENTITY
Entity: selection frequency, Type: ENTITY
Entity: criteria, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: deployments, Type: ENTITY
Entity: months, Type: ENTITY
Entity: months, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: deployments, Type: ENTITY
Entity: months, Type: ENTITY
Entity: statistically signiﬁcant, Type: ENTITY
Entity: days, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: post, Type: ENTITY
Entity: deployment serum, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: ferences, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: time intervals, Type: ENTITY
Entity: occupational code, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: post, Type: ENTITY
Entity: deployment diagnosis, Type: ENTITY
Entity: code frontiers, Type: ENTITY
Entity: psychiatry, Type: ENTITY
Entity: volume article, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: baseline, Type: ENTITY
Entity: characteristics, Type: ENTITY
Entity: population, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: younger, Type: ENTITY
Entity: years, Type: ENTITY
Entity: older years, Type: ENTITY
Entity: gender, Type: ENTITY
Entity: male, Type: ENTITY
Entity: female, Type: ENTITY
Entity: race, Type: ENTITY
Entity: white black, Type: ENTITY
Entity: long months, Type: ENTITY
Entity: time deployment, Type: ENTITY
Entity: post, Type: ENTITY
Entity: days, Type: ENTITY
Entity: days, Type: ENTITY
Entity: time deployment, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: days, Type: ENTITY
Entity: days, Type: ENTITY
Entity: occupational coding, Type: ENTITY
Entity: combat, Type: ENTITY
Entity: combat, Type: ENTITY
Entity: missing, Type: ENTITY
Entity: middle grade senior, Type: ENTITY
Entity: military, Type: ENTITY
Entity: combat, Type: ENTITY
Entity: combat, Type: ENTITY
Entity: junior enlisted, Type: ENTITY
Entity: middle senior enlisted ofﬁcer, Type: ENTITY
Entity: data, Type: ENTITY
Entity: analyses, Type: ENTITY
Entity: includ, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: evaluate, Type: ENTITY
Entity: potential, Type: ENTITY
Entity: analyses, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: concurrent, Type: ENTITY
Entity: multivariate anova, Type: ENTITY
Entity: post, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: exposure, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: signif, Type: ENTITY
Entity: reductions controls, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: trols, Type: ENTITY
Entity: position, Type: ENTITY
Entity: statistically signiﬁcant, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: patterns, Type: ENTITY
Entity: material, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: trols, Type: ENTITY
Entity: paired differences, Type: ENTITY
Entity: levels, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: post, Type: ENTITY
Entity: deployment controls, Type: ENTITY
Entity: post deployment, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: reduction, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: post, Type: ENTITY
Entity: deployment levels, Type: ENTITY
Entity: unchanged, Type: ENTITY
Entity: ment, Type: ENTITY
Entity: pattern, Type: ENTITY
Entity: decreased, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: post, Type: ENTITY
Entity: statistically niﬁcant, Type: ENTITY
Entity: decreases, Type: ENTITY
Entity: positions, Type: ENTITY
Entity: decrease, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: deployment controls, Type: ENTITY
Entity: increase, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: pattern, Type: ENTITY
Entity: decreased, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: post, Type: ENTITY
Entity: statistically niﬁcant, Type: ENTITY
Entity: decrease, Type: ENTITY
Entity: position, Type: ENTITY
Entity: pattern, Type: ENTITY
Entity: increased, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: post deployment, Type: ENTITY
Entity: comparisons, Type: ENTITY
Entity: statistically signiﬁcant, Type: ENTITY
Entity: material, Type: ENTITY
Entity: case comparisons, Type: ENTITY
Entity: post deployment, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: pattern, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: case, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: multivariate anova, Type: ENTITY
Entity: post, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: promoter value mean, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case mean, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case mean, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case mean, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case mean, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: promoter value, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: case position, Type: ENTITY
Entity: gender, Type: ENTITY
Entity: race, Type: ENTITY
Entity: samples, Type: ENTITY
Entity: post paired, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: pairs, Type: ENTITY
Entity: promoter regions, Type: ENTITY
Entity: sensitivity, Type: ENTITY
Entity: assay samples, Type: ENTITY
Entity: pyrosequencing, Type: ENTITY
Entity: assay mean, Type: ENTITY
Entity: post, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: deployment context, Type: ENTITY
Entity: people, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: post, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: material, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: deployment position, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: position mccases, Type: ENTITY
Entity: levels, Type: ENTITY
Entity: analyses table, Type: ENTITY
Entity: post, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: older years, Type: ENTITY
Entity: case males, Type: ENTITY
Entity: position, Type: ENTITY
Entity: case mean, Type: ENTITY
Entity: case service, Type: ENTITY
Entity: bers white, Type: ENTITY
Entity: case mean, Type: ENTITY
Entity: case deployments, Type: ENTITY
Entity: months, Type: ENTITY
Entity: case mean, Type: ENTITY
Entity: case discussion, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: post, Type: ENTITY
Entity: deployment signiﬁcant, Type: ENTITY
Entity: decrease, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls signiﬁcant, Type: ENTITY
Entity: decrease, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: increase, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: post, Type: ENTITY
Entity: younger service, Type: ENTITY
Entity: males, Type: ENTITY
Entity: service, Type: ENTITY
Entity: white race, Type: ENTITY
Entity: shorter, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: addi, Type: ENTITY
Entity: tional, Type: ENTITY
Entity: ﬁndings speciﬁc, Type: ENTITY
Entity: deployment case, Type: ENTITY
Entity: signals assay, Type: ENTITY
Entity: psychiatry, Type: ENTITY
Entity: volume article, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: multivariate anova, Type: ENTITY
Entity: post, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: gender race, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: promoter site, Type: ENTITY
Entity: subject, Type: ENTITY
Entity: younger, Type: ENTITY
Entity: younger older value value, Type: ENTITY
Entity: case cont, Type: ENTITY
Entity: female, Type: ENTITY
Entity: male, Type: ENTITY
Entity: female, Type: ENTITY
Entity: male, Type: ENTITY
Entity: value value, Type: ENTITY
Entity: case cont, Type: ENTITY
Entity: race, Type: ENTITY
Entity: black white black white value value, Type: ENTITY
Entity: case cont, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: case cont, Type: ENTITY
Entity: gender race analyses, Type: ENTITY
Entity: gender, Type: ENTITY
Entity: race analyses, Type: ENTITY
Entity: race, Type: ENTITY
Entity: gender analyses, Type: ENTITY
Entity: deployment length, Type: ENTITY
Entity: gender race, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: differentially, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: patterns, Type: ENTITY
Entity: markers, Type: ENTITY
Entity: vulnerability, Type: ENTITY
Entity: resiliency, Type: ENTITY
Entity: psychological stress, Type: ENTITY
Entity: incurred, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: response genes, Type: ENTITY
Entity: data controls, Type: ENTITY
Entity: response, Type: ENTITY
Entity: protective ptsd, Type: ENTITY
Entity: risk, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: promoter region, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: deployment difference, Type: ENTITY
Entity: positions, Type: ENTITY
Entity: signiﬁcance, Type: ENTITY
Entity: rever pattern, Type: ENTITY
Entity: levels, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: statistically signiﬁcant, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: inverselycorrelatedwithgeneexpression, Type: ENTITY
Entity: inparticularforimmune system, Type: ENTITY
Entity: genes, Type: ENTITY
Entity: oliveira, Type: ENTITY
Entity: ﬁndings, Type: ENTITY
Entity: cdna microarray, Type: ENTITY
Entity: investigation, Type: ENTITY
Entity: regulation, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: segman, Type: ENTITY
Entity: inﬂammatory cytokine mediator, Type: ENTITY
Entity: inﬂammation, Type: ENTITY
Entity: immune response, Type: ENTITY
Entity: interferon, Type: ENTITY
Entity: brain, Type: ENTITY
Entity: logical disorders, Type: ENTITY
Entity: anderson rodriguez, Type: ENTITY
Entity: attenuate, Type: ENTITY
Entity: breaks blood brain barrier, Type: ENTITY
Entity: independent, Type: ENTITY
Entity: pathway, Type: ENTITY
Entity: neuroprotective role jung, Type: ENTITY
Entity: increased, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: regulation thegene, Type: ENTITY
Entity: ziekeretal, Type: ENTITY
Entity: ﬁndings, Type: ENTITY
Entity: stress response, Type: ENTITY
Entity: imprinted locus, Type: ENTITY
Entity: growth, Type: ENTITY
Entity: hormone, Type: ENTITY
Entity: long coding maternally, Type: ENTITY
Entity: locus transcribes, Type: ENTITY
Entity: trans regulator, Type: ENTITY
Entity: imprinted, Type: ENTITY
Entity: embryonic growth, Type: ENTITY
Entity: micro mirna cunningham, Type: ENTITY
Entity: ctcf binding site, Type: ENTITY
Entity: paternal chromosome, Type: ENTITY
Entity: prevents, Type: ENTITY
Entity: binding ctcf insulator, Type: ENTITY
Entity: activation promoter, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: ctcf binding site, Type: ENTITY
Entity: maternal chromosome, Type: ENTITY
Entity: promoter, Type: ENTITY
Entity: tion, Type: ENTITY
Entity: keniry, Type: ENTITY
Entity: whole blood, Type: ENTITY
Entity: signal, Type: ENTITY
Entity: fear, Type: ENTITY
Entity: extinction, Type: ENTITY
Entity: therapeutic, Type: ENTITY
Entity: venue, Type: ENTITY
Entity: attenuate, Type: ENTITY
Entity: excessive, Type: ENTITY
Entity: fear, Type: ENTITY
Entity: neuronal, Type: ENTITY
Entity: neural stem cells, Type: ENTITY
Entity: interaction, Type: ENTITY
Entity: insulin receptor, Type: ENTITY
Entity: agis balboa, Type: ENTITY
Entity: ziegler, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: fear, Type: ENTITY
Entity: extinction, Type: ENTITY
Entity: regulation, Type: ENTITY
Entity: mirna products, Type: ENTITY
Entity: inhibition, Type: ENTITY
Entity: stress response, Type: ENTITY
Entity: investigated, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: repetitive ments line, Type: ENTITY
Entity: ential, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: post, Type: ENTITY
Entity: deployment controls, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: post, Type: ENTITY
Entity: speciﬁc, Type: ENTITY
Entity: cytokine, Type: ENTITY
Entity: promoter regions, Type: ENTITY
Entity: ﬁndings literature, Type: ENTITY
Entity: expression, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: cytokines, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: segman, Type: ENTITY
Entity: nowotny, Type: ENTITY
Entity: sarapas smith, Type: ENTITY
Entity: increasing, Type: ENTITY
Entity: evidence, Type: ENTITY
Entity: chemokine, Type: ENTITY
Entity: network, Type: ENTITY
Entity: torres, Type: ENTITY
Entity: aleman, Type: ENTITY
Entity: brain vasculature, Type: ENTITY
Entity: development, Type: ENTITY
Entity: target, Type: ENTITY
Entity: morbid, Type: ENTITY
Entity: conditions, Type: ENTITY
Entity: neuro chemokine, Type: ENTITY
Entity: brain, Type: ENTITY
Entity: neuroinﬂammation synaptic transmission, Type: ENTITY
Entity: cytokine, Type: ENTITY
Entity: immune cells, Type: ENTITY
Entity: expressing, Type: ENTITY
Entity: surface molecules, Type: ENTITY
Entity: neurophysiological, Type: ENTITY
Entity: potassium calcium channels methyl aspartate nmda receptor subunits, Type: ENTITY
Entity: neuronal phosphatases, Type: ENTITY
Entity: autocrine function, Type: ENTITY
Entity: brain, Type: ENTITY
Entity: neuropoiesis, Type: ENTITY
Entity: kurschner yuzaki schwab bannert, Type: ENTITY
Entity: chemokine, Type: ENTITY
Entity: inﬂammatory cytokine, Type: ENTITY
Entity: induce, Type: ENTITY
Entity: inﬂammatory mediator inter, Type: ENTITY
Entity: feron, Type: ENTITY
Entity: neuroprotective roles, Type: ENTITY
Entity: models, Type: ENTITY
Entity: neurodegenerative conditions, Type: ENTITY
Entity: speciﬁc, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: ressler trollope, Type: ENTITY
Entity: stud, Type: ENTITY
Entity: post blood samples, Type: ENTITY
Entity: cross sectional, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: individuals, Type: ENTITY
Entity: longi tudinal, Type: ENTITY
Entity: investigated, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: immune func tion proﬁles, Type: ENTITY
Entity: blood, Type: ENTITY
Entity: immune system functions, Type: ENTITY
Entity: signif, Type: ENTITY
Entity: overrepresented, Type: ENTITY
Entity: genes, Type: ENTITY
Entity: unmethylated, Type: ENTITY
Entity: uddin, Type: ENTITY
Entity: signature, Type: ENTITY
Entity: regulates, Type: ENTITY
Entity: innate, Type: ENTITY
Entity: evidence, Type: ENTITY
Entity: chemokines, Type: ENTITY
Entity: receptors, Type: ENTITY
Entity: regulate, Type: ENTITY
Entity: immune cell, Type: ENTITY
Entity: inﬁltration, Type: ENTITY
Entity: physiological functions, Type: ENTITY
Entity: neurotransmission, Type: ENTITY
Entity: neurogenesis, Type: ENTITY
Entity: neuro, Type: ENTITY
Entity: modulatory role, Type: ENTITY
Entity: balance neurotrans, Type: ENTITY
Entity: mitters, Type: ENTITY
Entity: affecting, Type: ENTITY
Entity: fear, Type: ENTITY
Entity: memory herry joels, Type: ENTITY
Entity: peripheral blood mononuclear cell, Type: ENTITY
Entity: expression proﬁle, Type: ENTITY
Entity: trauma, Type: ENTITY
Entity: survivors, Type: ENTITY
Entity: expressed, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: hypermethylation, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: segman, Type: ENTITY
Entity: human, Type: ENTITY
Entity: persons, Type: ENTITY
Entity: traumatic events, Type: ENTITY
Entity: increased, Type: ENTITY
Entity: risk, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: lower, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: serotonin transporter, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: levels, Type: ENTITY
Entity: individuals, Type: ENTITY
Entity: traumatic events, Type: ENTITY
Entity: ptsd koenen, Type: ENTITY
Entity: post, Type: ENTITY
Entity: deployment case difference, Type: ENTITY
Entity: psychiatry, Type: ENTITY
Entity: volume article, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: people, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: levels controls, Type: ENTITY
Entity: susceptibility, Type: ENTITY
Entity: devel, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: promoter region, Type: ENTITY
Entity: serum, Type: ENTITY
Entity: biomarker, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: cytokine, Type: ENTITY
Entity: promoter regions, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: human, Type: ENTITY
Entity: investigated, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: whole blood, Type: ENTITY
Entity: uddin, Type: ENTITY
Entity: koenen, Type: ENTITY
Entity: ressler trollope, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: brain tissues, Type: ENTITY
Entity: cytokines, Type: ENTITY
Entity: cross blood brain barrier, Type: ENTITY
Entity: alboni jung origin, Type: ENTITY
Entity: nucleic acids cell, Type: ENTITY
Entity: circulating, Type: ENTITY
Entity: stem necrosis, Type: ENTITY
Entity: apoptosis, Type: ENTITY
Entity: active release, Type: ENTITY
Entity: stroun goebel, Type: ENTITY
Entity: rhodes, Type: ENTITY
Entity: excessive, Type: ENTITY
Entity: stress, Type: ENTITY
Entity: induce, Type: ENTITY
Entity: damage, Type: ENTITY
Entity: oxidized, Type: ENTITY
Entity: nucleo sides strand breaks, Type: ENTITY
Entity: apoptosis, Type: ENTITY
Entity: necrosis, Type: ENTITY
Entity: life stress, Type: ENTITY
Entity: oxidative stress accumu, Type: ENTITY
Entity: lation, Type: ENTITY
Entity: reactive oxygen species, Type: ENTITY
Entity: increase, Type: ENTITY
Entity: susceptibility, Type: ENTITY
Entity: brain tissue, Type: ENTITY
Entity: molecular cascades, Type: ENTITY
Entity: blood brain barrier, Type: ENTITY
Entity: permeability neuronal death, Type: ENTITY
Entity: cultured cells, Type: ENTITY
Entity: clinical specimens, Type: ENTITY
Entity: whole blood serum, Type: ENTITY
Entity: brain tissue, Type: ENTITY
Entity: cell types, Type: ENTITY
Entity: unique, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: proﬁle, Type: ENTITY
Entity: ﬁnal analysis, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: patterns, Type: ENTITY
Entity: brain region, Type: ENTITY
Entity: iwamoto, Type: ENTITY
Entity: kato, Type: ENTITY
Entity: human, Type: ENTITY
Entity: cerebral cortex, Type: ENTITY
Entity: epigenetic signature, Type: ENTITY
Entity: cerebellum ladd acosta, Type: ENTITY
Entity: global, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: regions, Type: ENTITY
Entity: hippocam miller, Type: ENTITY
Entity: sweatt brown, Type: ENTITY
Entity: cortical cells, Type: ENTITY
Entity: epigenomic patterns, Type: ENTITY
Entity: serum methy lation, Type: ENTITY
Entity: surrogate, Type: ENTITY
Entity: indicator, Type: ENTITY
Entity: differential response, Type: ENTITY
Entity: intent, Type: ENTITY
Entity: invasive, Type: ENTITY
Entity: biomarker, Type: ENTITY
Entity: tissues, Type: ENTITY
Entity: signiﬁcance, Type: ENTITY
Entity: storage, Type: ENTITY
Entity: inﬂuenced, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: samples, Type: ENTITY
Entity: serum repository june, Type: ENTITY
Entity: serum, Type: ENTITY
Entity: subjects, Type: ENTITY
Entity: sample criteria, Type: ENTITY
Entity: january, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: post, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: storage, Type: ENTITY
Entity: time mean, Type: ENTITY
Entity: storage, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: years, Type: ENTITY
Entity: storage, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: post, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: years, Type: ENTITY
Entity: storage, Type: ENTITY
Entity: post, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: deployment mean, Type: ENTITY
Entity: years, Type: ENTITY
Entity: post, Type: ENTITY
Entity: years, Type: ENTITY
Entity: storage, Type: ENTITY
Entity: time trols, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: years, Type: ENTITY
Entity: post, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: post, Type: ENTITY
Entity: storage, Type: ENTITY
Entity: models, Type: ENTITY
Entity: storage, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: changes, Type: ENTITY
Entity: parsimonious model, Type: ENTITY
Entity: limitations, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: ment, Type: ENTITY
Entity: timing, Type: ENTITY
Entity: issue, Type: ENTITY
Entity: ptsd diagnosis, Type: ENTITY
Entity: exposed know, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: investigate, Type: ENTITY
Entity: bias, Type: ENTITY
Entity: disparity analyses, Type: ENTITY
Entity: group, Type: ENTITY
Entity: combat, Type: ENTITY
Entity: deployment group, Type: ENTITY
Entity: speciﬁed, Type: ENTITY
Entity: combat, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: patterns, Type: ENTITY
Entity: complete group, Type: ENTITY
Entity: data, Type: ENTITY
Entity: poten tial, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: experience, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: deployed, Type: ENTITY
Entity: active duty, Type: ENTITY
Entity: deployed, Type: ENTITY
Entity: months, Type: ENTITY
Entity: potential, Type: ENTITY
Entity: subjects, Type: ENTITY
Entity: intensity, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: data, Type: ENTITY
Entity: exposure, Type: ENTITY
Entity: personality, Type: ENTITY
Entity: traits, Type: ENTITY
Entity: hypothe, Type: ENTITY
Entity: sized inﬂuence, Type: ENTITY
Entity: vulnerability, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: zuiden, Type: ENTITY
Entity: military personnel, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: medical exam, Type: ENTITY
Entity: deployment assessment, Type: ENTITY
Entity: survey, Type: ENTITY
Entity: defense form, Type: ENTITY
Entity: medical, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: subjects, Type: ENTITY
Entity: sample collection, Type: ENTITY
Entity: heterogeneity, Type: ENTITY
Entity: interval serum, Type: ENTITY
Entity: dodsr, Type: ENTITY
Entity: timing, Type: ENTITY
Entity: testing, Type: ENTITY
Entity: military service, Type: ENTITY
Entity: data, Type: ENTITY
Entity: exposures inﬂu, Type: ENTITY
Entity: ence, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: dietary factors, Type: ENTITY
Entity: folate, Type: ENTITY
Entity: vitamin intake, Type: ENTITY
Entity: fenech, Type: ENTITY
Entity: piyathilake, Type: ENTITY
Entity: johanning, Type: ENTITY
Entity: smoking, Type: ENTITY
Entity: alcohol consumption seitz, Type: ENTITY
Entity: ascertainment, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: medical encounter, Type: ENTITY
Entity: deﬁnition, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: misclassi, Type: ENTITY
Entity: ﬁcation disease, Type: ENTITY
Entity: code, Type: ENTITY
Entity: diagnostic position, Type: ENTITY
Entity: calendar time, Type: ENTITY
Entity: case, Type: ENTITY
Entity: ment, Type: ENTITY
Entity: misclassiﬁcation, Type: ENTITY
Entity: ptsd case, Type: ENTITY
Entity: september department, Type: ENTITY
Entity: ptsd standardization, Type: ENTITY
Entity: military affairs, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: forces, Type: ENTITY
Entity: surveillance center, Type: ENTITY
Entity: sera, Type: ENTITY
Entity: potential, Type: ENTITY
Entity: limitation, Type: ENTITY
Entity: limitations, Type: ENTITY
Entity: post, Type: ENTITY
Entity: biologic samples, Type: ENTITY
Entity: trols, Type: ENTITY
Entity: case studies, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: patterns, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: vulnerabilities, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: strength, Type: ENTITY
Entity: lized pyrosequencing, Type: ENTITY
Entity: quantitative, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: quantitative real time, Type: ENTITY
Entity: sequenc technology light, Type: ENTITY
Entity: relative light unit, Type: ENTITY
Entity: qcpg software number quality, Type: ENTITY
Entity: assessments, Type: ENTITY
Entity: pass, Type: ENTITY
Entity: sample sequenced, Type: ENTITY
Entity: tions, Type: ENTITY
Entity: information, Type: ENTITY
Entity: sample quality, Type: ENTITY
Entity: speciﬁc, Type: ENTITY
Entity: ampliﬁcation speciﬁc sequencing, Type: ENTITY
Entity: pyrosequencing speciﬁc, Type: ENTITY
Entity: sample, Type: ENTITY
Entity: sample sufﬁcient, Type: ENTITY
Entity: quality, Type: ENTITY
Entity: chance, Type: ENTITY
Entity: statistically signiﬁcant, Type: ENTITY
Entity: ﬁndings report, Type: ENTITY
Entity: comparisons, Type: ENTITY
Entity: sample size, Type: ENTITY
Entity: exploratory, Type: ENTITY
Entity: preliminary, Type: ENTITY
Entity: serum samples, Type: ENTITY
Entity: military service, Type: ENTITY
Entity: investigations, Type: ENTITY
Entity: populations, Type: ENTITY
Entity: evidence, Type: ENTITY
Entity: molecular mechanisms, Type: ENTITY
Entity: regulate, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: synaptic plasticity, Type: ENTITY
Entity: learning memory, Type: ENTITY
Entity: fischer, Type: ENTITY
Entity: development, Type: ENTITY
Entity: biomarkers, Type: ENTITY
Entity: potential, Type: ENTITY
Entity: iﬁcations, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: methylating methylating agents, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: potential, Type: ENTITY
Entity: approaches, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: treatment, Type: ENTITY
Entity: methylation serum potential marker, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: personnel, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: reduced, Type: ENTITY
Entity: levels, Type: ENTITY
Entity: ment, Type: ENTITY
Entity: elevated, Type: ENTITY
Entity: levels deployment, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: vulnerability, Type: ENTITY
Entity: resilience, Type: ENTITY
Entity: speculation, Type: ENTITY
Entity: incidence, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: patterns, Type: ENTITY
Entity: acknowledgments, Type: ENTITY
Entity: authors, Type: ENTITY
Entity: declare, Type: ENTITY
Entity: ﬁnancial, Type: ENTITY
Entity: ests, Type: ENTITY
Entity: andrea baccarelli, Type: ENTITY
Entity: niehs, Type: ENTITY
Entity: gator, Type: ENTITY
Entity: zygmunt, Type: ENTITY
Entity: agency, Type: ENTITY
Entity: expressed, Type: ENTITY
Entity: scientiﬁc paper, Type: ENTITY
Entity: ofﬁcial, Type: ENTITY
Entity: policy, Type: ENTITY
Entity: defense authors, Type: ENTITY
Entity: data analysis, Type: ENTITY
Entity: interpretation, Type: ENTITY
Entity: celia, Type: ENTITY
Entity: byrne, Type: ENTITY
Entity: interpretation, Type: ENTITY
Entity: epidemiologic tors, Type: ENTITY
Entity: zygmunt, Type: ENTITY
Entity: interpretation, Type: ENTITY
Entity: cytokines genes, Type: ENTITY
Entity: design, Type: ENTITY
Entity: preparation samples, Type: ENTITY
Entity: statistical analyses, Type: ENTITY
Entity: matthew poulin, Type: ENTITY
Entity: measurement, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: interpretation, Type: ENTITY
Entity: liying ried, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: interpretation, Type: ENTITY
Entity: andrea baccarelli, Type: ENTITY
Entity: design, Type: ENTITY
Entity: expertise, Type: ENTITY
Entity: project, Type: ENTITY
Entity: interpretation, Type: ENTITY
Entity: ﬁndings authors, Type: ENTITY
Entity: ﬁnal, Type: ENTITY
Entity: material, Type: ENTITY
Entity: article, Type: ENTITY
Entity: online, Type: ENTITY
Entity: investigating, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: post, Type: ENTITY
Entity: cases, Type: ENTITY
Entity: post, Type: ENTITY
Entity: deployment table, Type: ENTITY
Entity: investigating, Type: ENTITY
Entity: controls, Type: ENTITY
Entity: deployment, Type: ENTITY
Entity: post, Type: ENTITY
Entity: balboa, Type: ENTITY
Entity: govindarajan, Type: ENTITY
Entity: burkhardt, Type: ENTITY
Entity: hippocampal, Type: ENTITY
Entity: insulin growth path, Type: ENTITY
Entity: regulates, Type: ENTITY
Entity: extinction, Type: ENTITY
Entity: fear, Type: ENTITY
Entity: memories embo, Type: ENTITY
Entity: alboni, Type: ENTITY
Entity: cervia, Type: ENTITY
Entity: sugama conti, Type: ENTITY
Entity: antiepileptics, Type: ENTITY
Entity: melatonin, Type: ENTITY
Entity: mulcahy, Type: ENTITY
Entity: stroun detec, Type: ENTITY
Entity: patients, Type: ENTITY
Entity: cancer metastasis, Type: ENTITY
Entity: forces, Type: ENTITY
Entity: surveillance center, Type: ENTITY
Entity: afhsc, Type: ENTITY
Entity: viewdocument casedefs, Type: ENTITY
Entity: hsiao mustak, Type: ENTITY
Entity: cell free plasma disease, Type: ENTITY
Entity: activ, Type: ENTITY
Entity: bannert, Type: ENTITY
Entity: vollhardt, Type: ENTITY
Entity: asomuddi haag, Type: ENTITY
Entity: konig domain, Type: ENTITY
Entity: interaction, Type: ENTITY
Entity: interleukin precursor proteins, Type: ENTITY
Entity: myosin phosphatase, Type: ENTITY
Entity: subunits biol chem frontiers, Type: ENTITY
Entity: psychiatry, Type: ENTITY
Entity: volume article, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: ciaramella, Type: ENTITY
Entity: salani, Type: ENTITY
Entity: palladino caltagirone, Type: ENTITY
Entity: interleukin neuroinﬂammation alzheimer disease curr, Type: ENTITY
Entity: breslau, Type: ENTITY
Entity: epidemiology, Type: ENTITY
Entity: posttraumatic stress disorder, Type: ENTITY
Entity: problem, Type: ENTITY
Entity: psychiatry, Type: ENTITY
Entity: weaver, Type: ENTITY
Entity: szyf, Type: ENTITY
Entity: regional speciﬁc, Type: ENTITY
Entity: global cytosine methylation methyltransferase, Type: ENTITY
Entity: expres sion, Type: ENTITY
Entity: adult, Type: ENTITY
Entity: hippocam neurosci lett neulet cruikshank, Type: ENTITY
Entity: lnterleukin, Type: ENTITY
Entity: regulating cell activation crit immunol critrevimmunol cunningham, Type: ENTITY
Entity: kassis, Type: ENTITY
Entity: cogni, Type: ENTITY
Entity: tive disorders, Type: ENTITY
Entity: imprinted genes cell, Type: ENTITY
Entity: devcel, Type: ENTITY
Entity: fenech, Type: ENTITY
Entity: folic acid, Type: ENTITY
Entity: genomic stability, Type: ENTITY
Entity: human cells, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: tral nervous system, Type: ENTITY
Entity: chiatric disorders, Type: ENTITY
Entity: loss insulin, Type: ENTITY
Entity: growth imprinting, Type: ENTITY
Entity: ccctc, Type: ENTITY
Entity: binding regulation, Type: ENTITY
Entity: senes, Type: ENTITY
Entity: human, Type: ENTITY
Entity: epithelial cells, Type: ENTITY
Entity: biol chem gavin sharma, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: schizophrenia, Type: ENTITY
Entity: biobehav neubiorev goebel, Type: ENTITY
Entity: zitt, Type: ENTITY
Entity: zitt, Type: ENTITY
Entity: muller, Type: ENTITY
Entity: nucleic acids, Type: ENTITY
Entity: plasma serum, Type: ENTITY
Entity: prognostic predictive mark, Type: ENTITY
Entity: patients, Type: ENTITY
Entity: solid neoplasias, Type: ENTITY
Entity: markers, Type: ENTITY
Entity: gormally caboux, Type: ENTITY
Entity: vineis hainaut circulating free, Type: ENTITY
Entity: biomarker carcinogenesis, Type: ENTITY
Entity: tical aspects, Type: ENTITY
Entity: biological, Type: ENTITY
Entity: signif, Type: ENTITY
Entity: mrrev shen interaction free, Type: ENTITY
Entity: metalloproteinases caveolin, Type: ENTITY
Entity: impacts, Type: ENTITY
Entity: blood brain barrier, Type: ENTITY
Entity: perme, Type: ENTITY
Entity: schol, Type: ENTITY
Entity: ciocchi senn, Type: ENTITY
Entity: muller, Type: ENTITY
Entity: switching, Type: ENTITY
Entity: fear, Type: ENTITY
Entity: hoge castro messer, Type: ENTITY
Entity: mcgurk, Type: ENTITY
Entity: koff, Type: ENTITY
Entity: combat, Type: ENTITY
Entity: duty iraq, Type: ENTITY
Entity: barriers care, Type: ENTITY
Entity: moshier pollack, Type: ENTITY
Entity: simon broad, Type: ENTITY
Entity: spec trum cytokine abnormalities, Type: ENTITY
Entity: panic disorder, Type: ENTITY
Entity: posttraumatic stress disorder, Type: ENTITY
Entity: depress, Type: ENTITY
Entity: anxiety, Type: ENTITY
Entity: iwamoto, Type: ENTITY
Entity: kato epigenetic proﬁling schizophre major, Type: ENTITY
Entity: mental disorders, Type: ENTITY
Entity: neuropsychobiology joels, Type: ENTITY
Entity: karst stress, Type: ENTITY
Entity: induced, Type: ENTITY
Entity: changes, Type: ENTITY
Entity: hippocampal, Type: ENTITY
Entity: prog, Type: ENTITY
Entity: brain, Type: ENTITY
Entity: interleukin, Type: ENTITY
Entity: attenuates, Type: ENTITY
Entity: disruption, Type: ENTITY
Entity: brain blood barrier, Type: ENTITY
Entity: induced, Type: ENTITY
Entity: status epilepticus, Type: ENTITY
Entity: piriform cortex, Type: ENTITY
Entity: interferon gamma inde pendent pathway, Type: ENTITY
Entity: brain brainres, Type: ENTITY
Entity: suppression, Type: ENTITY
Entity: cellular immunity, Type: ENTITY
Entity: posttraumatic stress disorder, Type: ENTITY
Entity: psychiatry, Type: ENTITY
Entity: lincrna, Type: ENTITY
Entity: developmental, Type: ENTITY
Entity: reservoir, Type: ENTITY
Entity: suppresses, Type: ENTITY
Entity: growth cell biol kessler david kendler childhood, Type: ENTITY
Entity: adversity, Type: ENTITY
Entity: adult, Type: ENTITY
Entity: psychiatric disorder, Type: ENTITY
Entity: national comorbidity, Type: ENTITY
Entity: kessler mcgonagle, Type: ENTITY
Entity: month, Type: ENTITY
Entity: prevalence, Type: ENTITY
Entity: iiir, Type: ENTITY
Entity: psychiatric disorders, Type: ENTITY
Entity: states, Type: ENTITY
Entity: national comorbidity survey, Type: ENTITY
Entity: chiatry, Type: ENTITY
Entity: kessler sonega bromet hughes nelson posttraumatic stress, Type: ENTITY
Entity: national comorbid survey arch, Type: ENTITY
Entity: psychia archpsyc koenen, Type: ENTITY
Entity: chang, Type: ENTITY
Entity: wildman goldmann, Type: ENTITY
Entity: modiﬁes, Type: ENTITY
Entity: traumatic events, Type: ENTITY
Entity: risk, Type: ENTITY
Entity: posttraumatic stress disor, Type: ENTITY
Entity: depress, Type: ENTITY
Entity: anxiety, Type: ENTITY
Entity: kuratomi, Type: ENTITY
Entity: iwamoto, Type: ENTITY
Entity: bundo, Type: ENTITY
Entity: aberrant, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: bipolar disorder, Type: ENTITY
Entity: discordant, Type: ENTITY
Entity: monozygotic twins, Type: ENTITY
Entity: psychiatry, Type: ENTITY
Entity: ciyan, Type: ENTITY
Entity: webster dinkins, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: signatures, Type: ENTITY
Entity: human, Type: ENTITY
Entity: brain genet, Type: ENTITY
Entity: maes delmeire, Type: ENTITY
Entity: kenis, Type: ENTITY
Entity: elevated, Type: ENTITY
Entity: interleukin receptor, Type: ENTITY
Entity: concentrations, Type: ENTITY
Entity: post, Type: ENTITY
Entity: traumatic stress disorder, Type: ENTITY
Entity: accidental, Type: ENTITY
Entity: matic events, Type: ENTITY
Entity: psychiatry, Type: ENTITY
Entity: ecular studies, Type: ENTITY
Entity: depressive disorder, Type: ENTITY
Entity: epigenetic perspec, Type: ENTITY
Entity: tive, Type: ENTITY
Entity: sweatt covalent modiﬁcation, Type: ENTITY
Entity: regulates, Type: ENTITY
Entity: memory, Type: ENTITY
Entity: neuron, Type: ENTITY
Entity: neuron, Type: ENTITY
Entity: nowotny cavka, Type: ENTITY
Entity: herder, Type: ENTITY
Entity: joksimovic, Type: ENTITY
Entity: acute, Type: ENTITY
Entity: chological stress glucose metab, Type: ENTITY
Entity: olism, Type: ENTITY
Entity: subclinical inﬂamma tion, Type: ENTITY
Entity: patients, Type: ENTITY
Entity: post, Type: ENTITY
Entity: traumatic stressdisorder horm metab, Type: ENTITY
Entity: andia salmon, Type: ENTITY
Entity: promoter oral cells, Type: ENTITY
Entity: smok smokers, Type: ENTITY
Entity: chronic periodontitis, Type: ENTITY
Entity: piyathilake, Type: ENTITY
Entity: cellular vitamins, Type: ENTITY
Entity: risk, Type: ENTITY
Entity: ressler mercer bradley, Type: ENTITY
Entity: kerley, Type: ENTITY
Entity: post, Type: ENTITY
Entity: traumatic stress disorder, Type: ENTITY
Entity: pacap receptor, Type: ENTITY
Entity: rhodes, Type: ENTITY
Entity: wort thomas, Type: ENTITY
Entity: collinson bennett, Type: ENTITY
Entity: mortality sepsis, Type: ENTITY
Entity: patients, Type: ENTITY
Entity: crit care rostene dansereau gode froy steenwinckel, Type: ENTITY
Entity: menage, Type: ENTITY
Entity: functions, Type: ENTITY
Entity: chemokines, Type: ENTITY
Entity: tral nervous system neurochem, Type: ENTITY
Entity: repetitive elements, Type: ENTITY
Entity: post, Type: ENTITY
Entity: traumatic stress disorder, Type: ENTITY
Entity: case military, Type: ENTITY
Entity: epigenomics, Type: ENTITY
Entity: kwon, Type: ENTITY
Entity: song, Type: ENTITY
Entity: protective effects, Type: ENTITY
Entity: interleukin interferon gamma neuronal damages, Type: ENTITY
Entity: hippocampus, Type: ENTITY
Entity: status epilepticus, Type: ENTITY
Entity: neuroscience neuroscience, Type: ENTITY
Entity: fischer, Type: ENTITY
Entity: epigenetic bottleneck, Type: ENTITY
Entity: psychiatric, Type: ENTITY
Entity: biol chem sarapas bierer, Type: ENTITY
Entity: genetic mark, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: resilience, Type: ENTITY
Entity: survivors, Type: ENTITY
Entity: trade center, Type: ENTITY
Entity: cary institute, Type: ENTITY
Entity: jaquet trabace krause, Type: ENTITY
Entity: severe, Type: ENTITY
Entity: life stress, Type: ENTITY
Entity: oxidative stress, Type: ENTITY
Entity: animal, Type: ENTITY
Entity: models, Type: ENTITY
Entity: human, Type: ENTITY
Entity: pathology, Type: ENTITY
Entity: antioxid, Type: ENTITY
Entity: june volume article, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: redox, Type: ENTITY
Entity: seid, Type: ENTITY
Entity: meyermann, Type: ENTITY
Entity: expressed, Type: ENTITY
Entity: human, Type: ENTITY
Entity: fetal, Type: ENTITY
Entity: brain, Type: ENTITY
Entity: microglial cells, Type: ENTITY
Entity: zones, Type: ENTITY
Entity: neuropoesis, Type: ENTITY
Entity: segman sheﬁ goltser, Type: ENTITY
Entity: friedman, Type: ENTITY
Entity: kaminski, Type: ENTITY
Entity: shalev, Type: ENTITY
Entity: peripheral blood mononuclear cell, Type: ENTITY
Entity: expres sion proﬁles, Type: ENTITY
Entity: emergent, Type: ENTITY
Entity: post, Type: ENTITY
Entity: traumatic stress disorder, Type: ENTITY
Entity: trauma, Type: ENTITY
Entity: survivors, Type: ENTITY
Entity: psychiatry, Type: ENTITY
Entity: seitz, Type: ENTITY
Entity: molecular mechanisms, Type: ENTITY
Entity: carcinogene cancer, Type: ENTITY
Entity: morganti, Type: ENTITY
Entity: chemokines, Type: ENTITY
Entity: pathology, Type: ENTITY
Entity: networks cereb, Type: ENTITY
Entity: metab jcbfm, Type: ENTITY
Entity: shimabukuro sasaki, Type: ENTITY
Entity: fuke, Type: ENTITY
Entity: umekage, Type: ENTITY
Entity: male, Type: ENTITY
Entity: patients, Type: ENTITY
Entity: schiz, Type: ENTITY
Entity: ophrenia, Type: ENTITY
Entity: potential, Type: ENTITY
Entity: epigenetics, Type: ENTITY
Entity: schizophrenia, Type: ENTITY
Entity: psychiatr, Type: ENTITY
Entity: jpsychires smith, Type: ENTITY
Entity: weiss bradley, Type: ENTITY
Entity: tial immune system methy, Type: ENTITY
Entity: cytokine regulation, Type: ENTITY
Entity: post, Type: ENTITY
Entity: genet, Type: ENTITY
Entity: neuropsychiatr, Type: ENTITY
Entity: genet, Type: ENTITY
Entity: spivak, Type: ENTITY
Entity: shohat mester, Type: ENTITY
Entity: interleukin beta, Type: ENTITY
Entity: combat, Type: ENTITY
Entity: posttraumatic stress disorder biol psychiatry stroun, Type: ENTITY
Entity: sand, Type: ENTITY
Entity: mechanism, Type: ENTITY
Entity: circulat, Type: ENTITY
Entity: apoptosis, Type: ENTITY
Entity: active release, Type: ENTITY
Entity: clin chim acta sutherland alexander hutchison disturbance, Type: ENTITY
Entity: inﬂammatory, Type: ENTITY
Entity: post, Type: ENTITY
Entity: traumatic, Type: ENTITY
Entity: netic aberration, Type: ENTITY
Entity: human, Type: ENTITY
Entity: reelin, Type: ENTITY
Entity: psychiatric disor, Type: ENTITY
Entity: ders, Type: ENTITY
Entity: psychiatry thomas, Type: ENTITY
Entity: hoge, Type: ENTITY
Entity: prevalence, Type: ENTITY
Entity: mental problems, Type: ENTITY
Entity: tional impairment, Type: ENTITY
Entity: active component, Type: ENTITY
Entity: national guard diers, Type: ENTITY
Entity: months, Type: ENTITY
Entity: combat, Type: ENTITY
Entity: iraq arch, Type: ENTITY
Entity: chiatry, Type: ENTITY
Entity: archgenpsychiatry, Type: ENTITY
Entity: ohgaki, Type: ENTITY
Entity: sakamoto, Type: ENTITY
Entity: egashira alcohol, Type: ENTITY
Entity: development, Type: ENTITY
Entity: squa, Type: ENTITY
Entity: mous cell carcinoma, Type: ENTITY
Entity: esopha, Type: ENTITY
Entity: molecular mechanisms, Type: ENTITY
Entity: cinogenesis, Type: ENTITY
Entity: clin oncol torres, Type: ENTITY
Entity: aleman, Type: ENTITY
Entity: comprehensive, Type: ENTITY
Entity: neurobiology, Type: ENTITY
Entity: dneu trollope, Type: ENTITY
Entity: mecinas, Type: ENTITY
Entity: collins, Type: ENTITY
Entity: saunderson, Type: ENTITY
Entity: reul stress, Type: ENTITY
Entity: epigenetic expression memory formation, Type: ENTITY
Entity: expneurol, Type: ENTITY
Entity: uddin, Type: ENTITY
Entity: wildman koenen, Type: ENTITY
Entity: pawelec, Type: ENTITY
Entity: santos, Type: ENTITY
Entity: genetic immune function proﬁles, Type: ENTITY
Entity: posttrau, Type: ENTITY
Entity: matic stress disorder proc natl acad pnas, Type: ENTITY
Entity: galea chang, Type: ENTITY
Entity: wildman, Type: ENTITY
Entity: santos, Type: ENTITY
Entity: expression, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: zuiden gueze, Type: ENTITY
Entity: wille vermetten, Type: ENTITY
Entity: high, Type: ENTITY
Entity: glucocorticoid receptor, Type: ENTITY
Entity: devel, Type: ENTITY
Entity: opment, Type: ENTITY
Entity: posttraumatic stress, Type: ENTITY
Entity: military, Type: ENTITY
Entity: ment, Type: ENTITY
Entity: psychiatry, Type: ENTITY
Entity: appi, Type: ENTITY
Entity: kanel, Type: ENTITY
Entity: keel mica, Type: ENTITY
Entity: evidence, Type: ENTITY
Entity: grade, Type: ENTITY
Entity: systemic, Type: ENTITY
Entity: tory activity, Type: ENTITY
Entity: patients, Type: ENTITY
Entity: post, Type: ENTITY
Entity: traumatic stress disorder, Type: ENTITY
Entity: psychi bollati, Type: ENTITY
Entity: taran tini, Type: ENTITY
Entity: marinelli, Type: ENTITY
Entity: cantone, Type: ENTITY
Entity: predictors, Type: ENTITY
Entity: global, Type: ENTITY
Entity: blood healthy, Type: ENTITY
Entity: subjects, Type: ENTITY
Entity: ziegler schneider, Type: ENTITY
Entity: tyler, Type: ENTITY
Entity: stemness, Type: ENTITY
Entity: stem cells stem, Type: ENTITY
Entity: zieker jatzko, Type: ENTITY
Entity: diet, Type: ENTITY
Entity: zsch, Type: ENTITY
Entity: nieselt, Type: ENTITY
Entity: expression peripheral blood, Type: ENTITY
Entity: patients, Type: ENTITY
Entity: suffering, Type: ENTITY
Entity: post, Type: ENTITY
Entity: traumatic stress disorder, Type: ENTITY
Entity: letter editor psychiatry, Type: ENTITY
Entity: sweatt, Type: ENTITY
Entity: epigenetic mechanisms, Type: ENTITY
Entity: fear, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: statement, Type: ENTITY
Entity: authors, Type: ENTITY
Entity: research, Type: ENTITY
Entity: absence, Type: ENTITY
Entity: mercial, Type: ENTITY
Entity: ﬁnancial, Type: ENTITY
Entity: relationships, Type: ENTITY
Entity: construed, Type: ENTITY
Entity: potential, Type: ENTITY
Entity: ﬂict, Type: ENTITY
Entity: citation, Type: ENTITY
Entity: poulin, Type: ENTITY
Entity: ptsd, Type: ENTITY
Entity: methylation, Type: ENTITY
Entity: immune function, Type: ENTITY
Entity: promoter regions, Type: ENTITY
Entity: military service, Type: ENTITY
Entity: psychiatry fpsyt, Type: ENTITY
Entity: psychiatry, Type: ENTITY
Entity: federal, Type: ENTITY
Entity: employees, Type: ENTITY
Entity: mons, Type: ENTITY
Entity: attribution license, Type: ENTITY
Entity: mits, Type: ENTITY
Entity: distribution, Type: ENTITY
Entity: subject, Type: ENTITY
Entity: graphics, Type: ENTITY
Entity: psychiatry, Type: ENTITY
Entity: volume article, Type: ENTITY

==================================================
Part-of-Speech Tags:
Token: psychiatry, POS Tag: NOUN
Token: original, POS Tag: ADJ
Token: research, POS Tag: NOUN
Token: article, POS Tag: NOUN
Token: published, POS Tag: VERB
Token: june, POS Tag: X
Token: fpsyt, POS Tag: NOUN
Token: ptsd, POS Tag: NOUN
Token: methylation, POS Tag: NOUN
Token: select, POS Tag: ADJ

==================================================
Sample Results Complete.